Ticker > Company >

Raaj Medisafe India share price

Raaj Medisafe India Ltd.

  20.17 K   55   2 BSE: 524502 SECTOR: Medical Equipment/Supplies/Accessories

93.80
-3.15 (-3.25%)
BSE: Today, 10:09 AM

Price Summary

Today's High

₹ 93.8

Today's Low

₹ 93.8

52 Week High

₹ 110.9

52 Week Low

₹ 64.08

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 154.06 Cr.

Enterprise Value

₹ 205.18 Cr.

No. of Shares

1.64 Cr.

P/E

100.04

P/B

3.11

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  30.21

CASH

₹ 13.01 Cr.

DEBT

₹ 64.13 Cr.

Promoter Holding

59.08 %

EPS (TTM)

₹  0.94

Sales Growth

28.19%

ROE

4.91 %

ROCE

11.94%

Profit Growth

-70.48 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year28.19%
3 Year27.48%
5 Year20.26%

Profit Growth

1 Year-70.48%
3 Year-18.48%
5 Year-4.35%

ROE%

1 Year4.91%
3 Year24.57%
5 Year49.27%

ROCE %

1 Year11.94%
3 Year15.52%
5 Year19.83%

Debt/Equity

1.3721

Price to Cash Flow

42.04

Interest Cover Ratio

2.5952

CFO/PAT (5 Yr. Avg.)

0.594604325267836

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2026 59.08 0.00
Jun 2026 59.08 0.00
Mar 2026 73.80 0.00
Dec 2025 73.80 0.00
Sep 2025 73.80 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 27.4792742892924% for the Past 3 years.
  • The company has an efficient Cash Conversion Cycle of 84.1568 days.
  • The company has a high promoter holding of 59.08%.

 Limitations

  • The company has shown a poor profit growth of -18.3911036887857% for the Past 3 years.
  • The company is trading at a high PE of 100.04.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Net Sales 18.4 20.71 25.08 29.46 30.08
Total Expenditure 15.66 17.02 22.37 25.4 26.49
Operating Profit 2.75 3.69 2.71 4.06 3.6
Other Income 0.23 0.04 0.28 0.15 0.06
Interest 0.82 1.38 1.08 0.86 0.99
Depreciation 0.43 0.5 0.63 0.71 1.04
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.73 1.85 1.29 2.64 1.62
Tax 0 -0.05 4.51 0.67 0.73
Profit After Tax 1.73 1.9 -3.23 1.97 0.9
Adjusted EPS (Rs) 1.31 1.44 -1.96 1.2 0.55

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 34.69 38.62 43.25 62.42 80.01
Total Expenditure 29.61 33.01 36.63 53.9 68.25
Operating Profit 5.09 5.61 6.62 8.52 11.76
Other Income 0.03 0.02 0.07 0.31 0.56
Interest 0.71 1.11 1.57 2.13 3.96
Depreciation 0.72 0.75 0.84 1.45 2.04
Exceptional Items 0.05 0 0 0 0
Profit Before Tax 3.73 3.77 4.29 5.25 6.32
Tax 0.71 0.44 0.96 -0.88 4.51
Net Profit 3.08 3.34 3.35 6.13 1.81
Adjusted EPS (Rs.) 2.76 3.05 3.05 4.65 1.1

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 10.9 10.9 10.9 13.18 16.42
Total Reserves -6.75 -3.41 -0.07 13.74 30.32
Borrowings 5.38 6.58 13.84 14.37 36.49
Other N/C liabilities 0.58 0.38 0.72 -1.08 2.81
Current liabilities 9.51 11.32 15.88 27.63 35.31
Total Liabilities 19.62 25.77 41.29 67.83 121.35
Assets
Net Block 9.3 8.63 10.72 23.68 39.04
Capital WIP 0 1.59 10.14 8.51 26.76
Intangible WIP 0 0 0 0 0
Investments 0.07 0.07 0.07 0 0
Loans & Advances 0.2 0.23 1.37 5.95 4.46
Other N/C Assets 0.04 0.04 0.48 0.07 0.63
Current Assets 10 15.2 18.49 29.62 50.45
Total Assets 19.62 25.77 41.29 67.83 121.35
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 3.73 3.78 4.31 5.19 6.32
Adjustment 1.54 1.85 2.34 3.38 5.41
Changes in Assets & Liabilities -2.82 -4.82 -1.7 -7.71 -8.07
Tax Paid 0 -0.64 -0.67 -0.95 0
Operating Cash Flow 2.45 0.17 4.27 -0.09 3.67
Investing Cash Flow -0.96 -1.67 -13 -16.42 -34.95
Financing Cash Flow -1.47 1.49 8.74 16.52 44.23
Net Cash Flow 0.02 -0.01 0.02 0.02 12.95

Corporate Actions

Investors Details

PARTICULARS Sep 2025% Dec 2025% Mar 2026% Jun 2026% Sep 2026%
promoters 73.80 73.80 73.80 59.08 59.08
anand bangur 11.29 11.29 11.29 9.04 9.04
arpit bangur 2.54 2.54 2.54 2.03 2.03
arpit packaging private l... 3.77 3.77 3.77 3.02 3.02
baldeo mangilal huf - - - - 12.90
mangla bangur 2.54 2.54 2.54 2.03 2.03
samiksha bangur - 2.54 2.54 2.03 2.03
shweta jajoo 3.65 3.65 3.65 2.92 2.92
sushen remedies private l... 19.24 19.24 19.24 15.40 15.40
vishnu jajoo 6.17 6.17 6.17 4.94 4.94
vishnu jajoo huf - - - - 1.35
vyanktesh securities priv... 4.26 4.26 4.26 3.41 3.41
baldeo mangilal 16.11 16.11 16.11 12.90 -
brahma swaroop jajoo 1.48 1.48 1.48 1.19 -
krishna jajoo 0.21 0.21 0.21 0.16 -
samiskha bangur 2.54 - - - -
PARTICULARS Sep 2025% Dec 2025% Mar 2026% Jun 2026% Sep 2026%
investors 26.20 26.20 26.20 40.92 40.92
ankit yadav - - - 1.33 1.33
binita singh - - - 1.05 1.05
dinesh patel - - - 3.32 3.32
govind maheshwari - - - 2.78 2.78
lifepulse medtech private... - - - 2.44 2.44
namit yadav - - - 1.33 1.33
ramesh chand maheshvari 2.44 2.44 2.44 1.95 1.95
seema patel - - - 3.32 3.32
sudhakar yadav - - - 1.33 1.33
yash ramesh brahmbhatt - - - 1.67 1.67

Annual Reports

Title Link
Title Link
Annual Report 2021
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Raaj Medisafe India informs about proceeding of AGM 22 Sep, 5:10 PM Raaj Medisafe India hits 52-week high on securing LoA worth Rs 17.02 crore 1 Sep, 11:22 AM Raaj Medisafe India secures LoA worth Rs 17.02 crore 31 Aug, 5:17 PM Raaj Medisafe India informs about confirmation certificate 10 Apr, 4:41 PM Raaj Medisafe India informs about closure of trading window 23 Mar, 3:33 PM Raaj Medisafe India - Quaterly Results 12 Feb, 12:00 AM Raaj Medisafe India informs about dispatch of letters 3 Sep, 4:16 PM Raaj Medisafe India informs about press release 13 Aug, 1:14 PM Raaj Medisafe India - Quaterly Results 11 Aug, 4:50 PM Raaj Medisafe India - Quaterly Results 11 Aug, 4:50 PM Raaj Medisafe India - Quaterly Results 11 Aug, 4:50 PM Raaj Medisafe India - Quaterly Results 11 Feb, 4:46 PM Raaj Medisafe India - Quaterly Results 11 Feb, 4:46 PM Raaj Medisafe India - Quaterly Results 11 Feb, 4:46 PM Raaj Medisafe India informs about loss of share certificates 9 Dec, 5:20 PM Raaj Medisafe India informs about loss of share certificates 7 Dec, 3:01 PM Raaj Medisafe India - Quaterly Results 14 Aug, 1:54 PM Raaj Medisafe India informs about compliance certificate 15 Apr, 5:23 PM Raaj Medisafe India - Quaterly Results 9 Feb, 4:29 PM Raaj Medisafe India - Quaterly Results 9 Feb, 4:29 PM Raaj Medisafe India - Quaterly Results 9 Feb, 4:29 PM Raaj Medisafe India informs about loss of share certificate 24 Jan, 4:55 PM Raaj Medisafe India informs about capacity expansion 16 Jan, 5:14 PM Raaj Medisafe India - Quaterly Results 8 Nov, 4:51 PM Raaj Medisafe India informs about loss of share certificate 12 Oct, 5:19 PM Raaj Medisafe India informs about outcome of board meeting 8 Aug, 5:03 PM Raaj Medisafe India - Quaterly Results 8 Aug, 4:27 PM Raaj Medisafe India - Quaterly Results 8 Aug, 4:27 PM Raaj Medisafe India - Quaterly Results 8 Aug, 4:27 PM Raaj Medisafe India informs about loss of share certificate 2 Jun, 5:02 PM Raaj Medisafe India - Quaterly Results 13 Feb, 4:42 PM Raaj Medisafe India - Quaterly Results 13 Feb, 4:42 PM Raaj Medisafe India informs about confirmation certificate 14 Oct, 3:16 PM Raaj Medisafe India - Quaterly Results 9 Aug, 5:56 PM Raaj Medisafe India - Quaterly Results 9 Aug, 5:56 PM Raaj Medisafe India informs about submission of related party transactions 7 Jun, 4:16 PM Raaj Medisafe India - Quaterly Results 25 May, 5:25 PM Raaj Medisafe India - Quaterly Results 25 May, 5:25 PM Raaj Medisafe India informs about certificate 21 Oct, 4:25 PM Raaj Medisafe India informs about revised financial results 15 Jul, 2:11 PM Raaj Medisafe India informs about compliance certificate 7 Jul, 4:54 PM Raaj Medisafe India to hold board meeting 8 Sep, 12:49 PM

Raaj Medisafe India Stock Price Analysis and Quick Research Report. Is Raaj Medisafe India an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Raaj Medisafe India. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Raaj Medisafe India has a PE ratio of 103.402303754266 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Raaj Medisafe India has ROA of 1.9133% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Raaj Medisafe India has a Current ratio of 1.4289.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Raaj Medisafe India has a ROE of 4.9142%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Raaj Medisafe India has a Debt to Equity ratio of 1.3721 which means that the company has low proportion of debt in its capital.

  • Sales growth: Raaj Medisafe India has reported revenue growth of 28.1866% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Raaj Medisafe India for the current financial year is 14.7023878454646%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Raaj Medisafe India is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Raaj Medisafe India is Rs 0.9376. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Raaj Medisafe India in Ticker for free. Also, one can get the intrinsic value of Raaj Medisafe India by using Valuation Calculators, which are available with a Finology ONE subscription. 

Raaj Medisafe India FAQs

Q1. What is Raaj Medisafe India share price today?
Ans: The current share price of Raaj Medisafe India is Rs 96.95.

Q2. What is the market capitalisation of Raaj Medisafe India?
Ans: Raaj Medisafe India has a market capitalisation of Rs 159.23370484 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Raaj Medisafe India?
Ans: The PE ratio of Raaj Medisafe India is 103.402303754266 and the P/B ratio of Raaj Medisafe India is 3.2094997219206, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Raaj Medisafe India share?
Ans: The 52-week high share price of Raaj Medisafe India is Rs 110.9, and the 52-week low share price of Raaj Medisafe India is Rs 64.08.

Q5. Does Raaj Medisafe India pay dividends?
Ans: Currently, Raaj Medisafe India does not pay dividends. Dividend yield of Raaj Medisafe India is around 0%.

Q6. What are the face value and book value of Raaj Medisafe India shares?
Ans: The face value of Raaj Medisafe India shares is Rs 10, while the book value per share of Raaj Medisafe India is around Rs 30.2072. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Raaj Medisafe India?
Ans: Raaj Medisafe India has a total debt of Rs 64.130752 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Raaj Medisafe India?
Ans: The ROE of Raaj Medisafe India is 4.9142% and ROCE of Raaj Medisafe India is 11.9397%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Raaj Medisafe India a good buy for the long term?
Ans: The Raaj Medisafe India long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Raaj Medisafe India undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Raaj Medisafe India appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Raaj Medisafe India’s financials?
Ans: You can review Raaj Medisafe India’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Raaj Medisafe India
X